Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

Immunology 30, 189–202 (1976). CAS PubMed PubMed Central Google Scholar Köhler, G. & Milstein, C. Derivation of specific antibody-producing tissue culture and cell lines by cell fusion.

After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found a ...

A new antibody has been developed to block immune suppression in aggressive breast cancer, offering a promising treatment.

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

British immunology firm Scancell has found a repeat buyer for its monoclonal antibodies. Genmab has plucked another anti-glycan antibody from Scancell’s shelves in a deal worth up to $630 million.

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

In a new study being published in Cell Reports, researchers from Prof. Idit Shachar’s laboratory at the Weizmann Institute of Science have discovered that a certain type of aggressive breast cancer ...

Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom ...

Stanford Medicine scientists have designed a way to make our seasonal influenza vaccinations more broadly effective and possibly to protect us from new flu variants with pandemic potential.